Search Results - "Plameňová, Ivana"

Several factors that predict the outcome of large B‐cell lymphoma patients who relapse/progress after chimeric antigen receptor (CAR) T‐cell therapy can be identified before cell administration by Sýkorová, Alice, Folber, František, Polgárová, Kamila, Móciková, Heidi, Ďuraš, Juraj, Steinerová, Kateřina, Obr, Aleš, Heindorfer, Adriana, Ladická, Miriam, Lukáčová, Ľubica, Čellárová, Erika, Plameňová, Ivana, Belada, David, Janíková, Andrea, Trněný, Marek, Jančárková, Tereza, Procházka, Vít, Vranovský, Andrej, Králiková, Margaréta, Vydra, Jan, Smolej, Lukáš, Drgoňa, Ľuboš, Sedmina, Martin, Čermáková, Eva, Pytlík, Robert

“…Aim The aim of this study was to analyse the outcomes of patients with large B‐cell lymphoma (LBCL) treated with chimeric antigen receptor T‐cell therapy…”
Get full text

The use of intravenous immunoglobulin in immune tolerance induction in inherited haemophilia A: a single-centre experience and a review of literature by Kubisz, Peter, Hollý, Pavol, Staško, Ján, Plameňová, Ivana

“…The immune tolerance induction is the treatment of choice for the eradication of factor VIII inhibitors, a serious complication of inherited haemophilia A…”
Get full text

Unusual Cause of Thrombocytopenia and Renal Failure in a 14-Year-Old Boy (MYH9-Associated Disorders) by Granak, Karol, Brndiarova, Miroslava, Vnucak, Matej, Plamenova, Ivana, Behulova Lohajova, Regina, Valencikova, Romana, Jesenak, Milos, Dedinska, Ivana

“…MYH9-associated disorders represent rare group of autosomal dominant diseases and are caused by pathogenic mutations in the MYH9 gene. Clinically, they are…”
Get full text

Multimer Analysis of Von Willebrand Factor in Von Willebrand Disease with a Hydrasys Semi-Automatic Analyzer-Single-Center Experience by Skornova, Ingrid, Simurda, Tomas, Stasko, Jan, Zolkova, Jana, Sokol, Juraj, Holly, Pavol, Dobrotova, Miroslava, Plamenova, Ivana, Hudecek, Jan, Brunclikova, Monika, Stryckova, Alena, Kubisz, Peter

“…von Willebrand disease (VWD) is reportedly the most common inherited bleeding disorder. This disorder develops as a result of defects and/or deficiency of the…”
Get full text

Prothrombin gene 20210A mutation in Slovak population by Chudej, Juraj, Plameňová, Ivana

“…Factor V Leiden (FVL) and prothrombin G20210A mutation (PTM) are the two most common genetic polymorphisms known to predispose to a first episode of venous…”
Get more information

Rituximab-associated progressive multifocal leukoencephalopathy by Sokol, Juraj, Lisá, Lenka, Zeleňáková, Jana, Balhárek, Tomáš, Plameňová, Ivana, Staško, Ján, Kubisz, Peter

“…The definition "Progressive Multifocal Leukoencephalopathy" (PML) was first used in 1958 to describe a fatal demyelinating central nervous system (CNS) disease…”
Get more information

Recombinant activated factor VII as an additional agent in the management of bleeding in patients with chemotherapy-induced thrombocytopenia by Hollý, Pavol, Lisá, Lenka, Plameňová, Ivana, Dobrotová, Miroslava, Kubisz, Peter

Get full text

Successful immune tolerance induction with high-dose coagulation factor VIII and intravenous immunoglobulins in a patient with congenital hemophilia and high-titer inhibitor of coagulation factor VIII despite unfavorable prognosis for the therapy by Kubisz, Peter, Plamenová, Ivana, Hollý, Pavol, Stasko, Ján

“…The production of factor VIII (FVIII) inhibitors is a serious problem of replacement therapy with FVIII concentrates in hemophiliacs. It affects 10-20%…”
Get more information

Successful immune tolerance induction consisting of high-dose factor VIII rich in von Willebrand factor and pulsed intravenous immunoglobulin: a case report by Kubisz, Peter, Plamenova, Ivana, Holly, Pavol, Stasko, Jan

“…The development of factor VIII inhibitors is a serious complication of replacement therapy in patients with congenital hemophilia A. Immune tolerance induction…”
Get full text

Long-term secondary prophylaxis with recombinant activated factor VII (rFVIIa) in haemophilia A with inhibitors: a case report by Kubisz, Peter, Plamenová, Ivana, Stasko, Ján, Dobrotová, Miroslava, Hollý, Pavol

Get more information

Genetic Background of Inherited Factor XIII-A Subunit Deficiency: Review of the Literature and Description of Two New Cases by Plamenova, Ivana, Zolkova, Jana, Sokol, Juraj, Kolkova, Zuzana, Bereczky, Zsuzsanna, Katona, Eva, Muszbek, Laszlo, Kubisz, Peter, Stasko, Jan

Get more information

Wiskott-Aldrich Syndrome Caused by a New Mutation Associated with Multifocal Dermal Juvenile Xanthogranulomas by Jesenak, Milos, Plamenova, Ivana, Plank, Lukas, Banovcin, Peter

“…Wiskott‐Aldrich syndrome is a rare X‐linked primary immunodeficiency clinically characterized by the triad of microthrombocytopenia, immunodeficiency, and…”
Get full text

C0221 Risk factors of thrombosis in patients with May-Thurner syndrome' case reports by Bartosova, Lenka, Plamenova, Ivana, Chuda, Daniela, Stasko, Jan, Kubisz, Peter

Get full text

Unusual Cause of Thrombocytopenia and Renal Failure in a 14-Year-Old Boy (MYH9-Associated Disorders) by Granak, Karol, Brndiarova, Miroslava, Vnucak, Matej, Plamenova, Ivana, Lohajova, Regina Behulova, Valencikova, Romana, Jesenak, Milos, Dedinska, Ivana

Get full text